Business Description
Parnell Pharmaceuticals Holdings Ltd
NAICS : 325412
SIC : 2834
ISIN : AU0000XINEU9
Compare
Compare
Traded in other countries / regions
PARNF.USA IPO Date
2014-06-18Description
Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 14.33 | |||||
| 6-1 Month Momentum % | -66.67 | |||||
| 12-1 Month Momentum % | -96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -16.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PARNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Parnell Pharmaceuticals Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 19.031 | ||
| EPS (TTM) ($) | 0.007 | ||
| Beta | 18.03 | ||
| Volatility % | 6585.11 | ||
| 14-Day RSI | 14.33 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -96 | ||
| 52-Week Range ($) | 0.0001 - 0.02 | ||
| Shares Outstanding (Mil) | 18.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Parnell Pharmaceuticals Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Parnell Pharmaceuticals Holdings Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Parnell Pharmaceuticals Holdings Ltd Frequently Asked Questions
What is Parnell Pharmaceuticals Holdings Ltd(PARNF)'s stock price today?
The current price of PARNF is $0.00. The 52 week high of PARNF is $0.02 and 52 week low is $0.00.
When is next earnings date of Parnell Pharmaceuticals Holdings Ltd(PARNF)?
The next earnings date of Parnell Pharmaceuticals Holdings Ltd(PARNF) is .
Does Parnell Pharmaceuticals Holdings Ltd(PARNF) pay dividends? If so, how much?
Parnell Pharmaceuticals Holdings Ltd(PARNF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers